Autonomic Dysfunction
- Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana
- Cannabinoid CB2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injury
- * Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis
- Cannabinoid pharmacology: the first 66 years
- Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
- * Cannabinoids and experimental models of multiple sclerosis
- Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta
- Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries
- Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart
- Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
- Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells
- * The endocannabinoid system and its therapeutic exploitation
- The endocannabinoid system as an emerging target of pharmacotherapy
- Vascular targets for cannabinoids: animal and human studies
The content of this page is controlled and sourced by A Third Party, who are in no way affiliated with the Natural Life Corporation.